Eyenovia, Inc. Acquires $50 Million in HYPE Tokens, Plans Validator Deployment and FDA Registration for Optejet UFD
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 23 2025
0mins
Should l Buy ?
Source: NASDAQ.COM
Eyenovia's Acquisition and Strategy: Eyenovia, Inc. has successfully closed a $50 million private placement to acquire over 1 million HYPE tokens, making it the first Nasdaq-listed company to operate a validator on the Hyperliquid blockchain, while also planning to change its name to "Hyperion DeFi."
Optejet UFD Development Update: The company is on track for FDA registration of its Optejet User Filled Device by September 2025 and is actively pursuing partnerships for licensing related to OTC lens rewetting and artificial tears.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
